In previous experiments using a hematogenous metastasis model, preliminary immunohistochemical staining of tumor tissues showed significant increases in IFN-γ and PD-1 expression within the dPEDE-A@M32 treatment group (Figure 7A). The gene discussed is PDCD1; the disease is neoplasm.